BIT's 16th Annual Congress of International Drug Discovery Science and Technology-2018
Welcome to IDDST-2018

BIT's 16th Annual Congress of International Drug Discovery Science and Technology-2018 (IDDST-2018) will be held on August 16-18, 2018 in Boston, USA.
Since its stage established in 2003, the annual IDDST Congress has differentiated itself as a major event updating the breaking research of drug discovery and development for both academic and industrial professionals with strong scientific program ever since. As a branded Conference of BIT Congress, IDDST continues to expand with magnificent scientific and social programs to maximize your network in a free communication meeting environment.
IDDST-2018 will provide a unique and ideal opportunity in life sciences of Drug Discovery, practical pharmaceutical sciences, clinical studies, industrial R & D and pipeline new drugs and translational medicine for industrial executives, academic professors, investors, marketing people and governmental policymakers. With the participation of outstanding international experts, we hope productive discussions would stimulate new creative ideas of latest developments in drug discovery and therapy.
We hope your participation would contribute to your professional development and relationships. Wish you enjoy the conference.

Renowned Speakers of IDDST-2018
说明: Dr. Gregory L. Verdine, Professor, Harvard University, USA 说明: Dr. Laszlo Urban, Executive Director, Novartis Institutes for BioMedical Research, USA 说明: Dr. Lawrence Friedhoff, Chief, Research & Development, Roivant Sciences, Inc., USA
说明: Dr. Daryl C. Drummond, Senior Vice President and Head of Research, Merrimack Pharmaceuticals, USA 说明: Dr. Kenneth G. Faulkner, Corporate Vice President, Patient Technology Solutions, PAREXEL, USA 说明: Dr. Qun (Max) Dang, Vice President, PR&D, Institute of Pharmaceutical Research and Development, Qilu Pharmaceutical, China
说明: Dr. John Delaney, Executive Director, Amgen Inc., USA 说明: Dr. Tycho H. Heimbach, Director, PK Sciences, Novartis Pharmaceuticals Corporation, Switzerland 说明: Dr. Naitee Ting, Director, Department of Biostatistics & Data Sciences, Boehringer-Ingelheim Pharmaceuticals Inc., USA
说明: Dr. Shanrong Zhao, Director, Computational Biology and Bioinformatics, Pfizer Worldwide Research & Development, Pfizer, Inc., USA 说明: Dr. Gyungah Jun, Director and Head, Neurogenetics and Integrated Genomics Integrated Human Genomics (IHGx), CCLO-PCHQ, Eisai, Inc., USA 说明: Dr. Jayaprakasam Bolleddula, Associate Director, Takeda Pharmaceuticals Int Co., USA
说明: Dr. Dietmar Wolf, Executive Vice President, AnalytiCon Discovery, LCC, Germany 说明: Dr. Kerstin Walke, Head of Pharmaceutical Development Biologicals, Boehringer Ingelheim Pharma GmbH & Co. KG, Germany 说明: Dr. Niclas Nilsson, Head of RD Open Innovation, LEO Pharma A/S, Denmark
说明: Dr. Robert W. Lee, Executive Vice President, Particle Sciences, Inc., USA 说明: Dr. Raul Insa, Founder and CEO, SOM Biotech, Spain 说明: Dr. Alain L. Fymat, President/CEO, International Institute of Medicine and Science California, USA
说明: Dr. Jack T. Rogers, Director of Neurochemistry Laboratory, Massachusetts General Hospital, Harvard University, USA 说明: Dr. Bakhos A. Tannous, Director, Harvard Medical School and Massachusetts General Hospital, USA 说明: Dr. Irwin J. Kurland, Director, Albert Einstein College of Medicine, USA
Programmed chapters at a glance
Stream 0 Open the Glory Hall of Drug Innovators
-Registration Day and Ice Breaking Party
Stream 1 Big Mind Bay
-Rethinking the Next Big Things in Drug Discovery
Stream 2 Creative Explorer’s Hubs
-New Paradigms in Next Generation Drug Discovery
Stream 3 Industrial Art Gallery
-Arts in Billion Dollar Molecules and Next Generation Therapy
Stream 4 Drug Discovery Bazaar
-Posters and Exhibits
Stream 5 Joyful Commune
-Sharing the Diversities for Common Interests
Past Conference Report
Opening Ceremony
Past Conference Report of IDDST-Japan 2017

BIT's 15th Annual Congress of International Drug Discovery Science and Technology-Japan 2017 (IDDST-Japan 2017) which was held in Hyatt Regency Osaka, Osaka, Japan on July 25-27, achieved a consummation. The theme of this conference is “Dedicated to Accelerating Drug Innovation". Over 400 honored guests presented at the ceremony and gave brilliant speeches on invitation, among them are 2010 Nobel Prize Laureate in Chemistry Dr. Ei-ichi Negishi, H. C. Brown Distinguished Professor of Chemistry in Purdue University; Dr. Howard J. Federoff, Vice Chancellor of Health Affairs and Chief Executive Officer of Health System in University of California, Irvine; Dr. Litao Zhang, Vice President of Bristol-Myers Squibb; Dr. Jan Hoflack, Chief Scientific and Operational Officer of Oncodesign SA; Dr. Akiyoshi Suganuma, Group Officer and President of BA-CFU in Medicine Development Center, Eisai Co., Ltd., Dr. David C. Bunton, CEO of REPROCELL Europe Ltd. …etc.

. . . View more
Analysis of Attendees Last Year
Scenery of Boston

Boston is one of the oldest cities in the United States, founded on the Shawmut Peninsula in 1630 by Puritan settlers from England. The area's many colleges and universities make Boston an international center of higher education, including law, medicine, engineering, and business, and the city is considered to be a world leader in innovation and entrepreneurship, with nearly 2,000 start-ups. Boston's economic base also includes finance, professional and business services, biotechnology, information technology, and government activities.

News Release
Full Program Released 说明:
● Call for Supporting Organizations and Media Partners
● Call for Session Chairs and Speakers 
● Call for Exhibitors and Sponsors
Hosting Organization

BIT Group Global Ltd
Supporting Organizations

AISI - American International Standard Institute

The National Hospital Pharmacists Association of Romanian

Media Partner List
BIT's Upcoming Events

© 2003-2018 All rights reserved by BIT Congress Inc.
Contact Us: Tel: 0086-411-84799609, Fax: 0086-411-84796897